Dashboard
1
High Management Efficiency with a high ROCE of 22.28%
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Poor long term growth as Operating profit has grown by an annual rate 1.95% of over the last 5 years
4
Positive results in Mar 25
5
With ROE of 13.62%, it has a very expensive valuation with a 3.13 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.35%
0%
17.35%
6 Months
19.74%
0%
19.74%
1 Year
-7.3%
0%
-7.3%
2 Years
-2.02%
0%
-2.02%
3 Years
30.95%
0%
30.95%
4 Years
5.1%
0%
5.1%
5 Years
30.33%
0%
30.33%
NEUCA SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.19%
EBIT Growth (5y)
1.95%
EBIT to Interest (avg)
6.45
Debt to EBITDA (avg)
0.55
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
7.89
Tax Ratio
25.12%
Dividend Payout Ratio
46.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.28%
ROE (avg)
15.97%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.13
EV to EBIT
14.39
EV to EBITDA
9.75
EV to Capital Employed
2.52
EV to Sales
0.29
PEG Ratio
NA
Dividend Yield
2.14%
ROCE (Latest)
17.54%
ROE (Latest)
13.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
3,365.90
3,221.00
4.50%
Operating Profit (PBDIT) excl Other Income
111.60
80.60
38.46%
Interest
21.30
14.50
46.90%
Exceptional Items
0.00
0.00
Consolidate Net Profit
50.60
24.50
106.53%
Operating Profit Margin (Excl OI)
23.90%
15.50%
0.84%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 4.50% vs 1.12% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 106.53% vs -51.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
12,611.80
11,812.60
6.77%
Operating Profit (PBDIT) excl Other Income
363.50
365.80
-0.63%
Interest
73.40
84.30
-12.93%
Exceptional Items
16.30
10.30
58.25%
Consolidate Net Profit
171.60
159.50
7.59%
Operating Profit Margin (Excl OI)
19.30%
21.30%
-0.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.77% vs 5.17% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 7.59% vs 6.76% in Dec 2023
About NEUCA SA 
NEUCA SA
Retailing
Neuca SA is a Poland-based company, which operates in the healthcare market. The Company is mainly involved in the distribution of drugs to pharmacies. It also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
Company Coordinates 
Company Details
Ul. Szosa Bydgoska 58 , TORUN None : 87-100
Registrar Details






